Juan Carlos Canale, MD
Gastroenterology · Turlock
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 53 years
- Graduated 1973
Offices
1 location
Hospitals listed: Doctors Medical Center · Emanuel Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Canale’s office at (209) 669-6060 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Doctors Medical CenterModesto, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.36 (1.02 to 1.71), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.35 (0.81 to 1.9) · 6,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.281, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.326, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.183, Oct 2024 – Sep 2025
- Emanuel Medical CenterTurlock, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.231, Oct 2024 – Sep 2025
See every measure and the patient survey for Doctors Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 3 the same, 1 worse of 6 measures. Readmissions: 0 better, 5 the same, 3 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.36 (1.02 to 1.71) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.35 (0.81 to 1.9) · 6,296 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.281 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.326 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.183 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.31 to 2.23) · 1,396 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 183.31 (147.26 to 219.36) · 127 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 4.1 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.1 · 95 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 15.2 · 276 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.8 · 321 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 364 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.9 · 767 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 3,719 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 7,050 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,169 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.12 (2.19 to 6.06) · 1,622 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.6 (0 to 3.3) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.23 to 4.04) · 1,601 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 14.79 (5.73 to 23.85) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (0.75 to 9.23) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.9 · 67 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.484 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.582 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 424 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24 · 682 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 36.6 · 326 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 70.5 · 378 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 366 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 564 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 70 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.7 · 120 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.4) · 573 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.7) · 303 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,045 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 57% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 36% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Emanuel Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.231 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.94) · 622 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.46 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.82 (131.99 to 239.65) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.8 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 287 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 365 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 443 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 1,680 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 4,151 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.53 (1.2 to 5.87) · 700 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.43) · 734 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.04) · 3,326 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 45 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.908 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.836 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.997 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 307 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 461 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -12.8 · 290 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.8 · 417 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 37.9 · 472 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.1 · 524 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.9 to 7.6) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (7.4 to 12.8) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.5 to 19.3) · 257 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 289 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 14% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$68,848
Medicare paid this office $68,848 for 492 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 115 | $17,481 | $151 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 62 | $10,398 | $168 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 142 | $8,507 | $59 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 51 | $8,477 | $166 |
| New patient visit (15+ min) | 185 | $7,344 | $40 |
See all 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 115 | $17,481 | $151 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 62 | $10,398 | $168 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 142 | $8,507 | $59 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 51 | $8,477 | $166 |
| New patient visit (15+ min) | 185 | $7,344 | $40 |
| Short return visit | 164 | $6,740 | $33 |
| Diagnostic exam of large bowel using a flexible endoscope | 40 | $4,519 | $113 |
| Short return visit (20+ min) | 60 | $3,304 | $54 |
| New patient visit (30+ min) | 22 | $1,653 | $75 |
Procedures Medicare counted
| Colonoscopy | 493 | More than 99% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 227 | More than 92% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 234 | 152 | 160 | 158 | 166 | 144 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 165 | 99 | 92 | 156 | 132 | 116 |
| Diagnostic exam of large bowel using a flexible endoscope | 120 | 83 | 67 | 59 | 47 | 40 |
| Biopsy of large bowel using a flexible endoscope | 16 | – | – | – | – | – |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 12 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
492 Original Medicare patients in 2024. Average age 69 · Under 65 19% · 85 and older 4% · Women 59% · Also on Medicaid 74% · Health risk score 1.29. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 48% · Coronary heart disease 20% · Chronic kidney disease 19% · Depression 18% · COPD 14% · Heart failure 13% · Cancer 11% · Atrial fibrillation 11% · Stroke 7%.
The office billed $373,285, Medicare allowed $96,733 and paid $68,848; for 892 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 492 | 892 | 69 | 1.29 | $373,285 | $68,848 |
| 2023 | 592 | 1,093 | 68 | 1.12 | $413,215 | $92,547 |
| 2022 | 619 | 1,173 | 68 | 1.21 | $454,280 | $103,011 |
| 2021 | 480 | 1,004 | 68 | 1.18 | $352,955 | $83,092 |
| 2020 | 527 | 1,022 | 68 | 1.23 | $350,230 | $69,556 |
| 2019 | 743 | 1,430 | 68 | 1.24 | $587,510 | $124,152 |
| 2018 | 807 | 1,493 | 67 | 1.13 | $619,265 | $128,547 |
| 2017 | 684 | 1,250 | 67 | 1.25 | $551,615 | $113,532 |
| 2016 | 741 | 1,362 | 67 | 1.16 | $588,835 | $131,010 |
| 2015 | 717 | 1,307 | 67 | 1.16 | $563,605 | $138,529 |
| 2014 | 635 | 1,160 | 67 | 1.10 | $455,400 | $129,253 |
| 2013 | 622 | 1,308 | 67 | 1.15 | $459,235 | $133,837 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 131 | $25,518 | $193 |
| New patient visit (15+ min) | 286 | $13,499 | $47 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 165 | $12,142 | $73 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 61 | $11,309 | $185 |
| Short return visit | 200 | $8,667 | $35 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 43 | $7,963 | $185 |
| Diagnostic exam of large bowel using a flexible endoscope | 47 | $5,903 | $126 |
| Short return visit (20+ min) | 79 | $4,798 | $61 |
| New patient visit (30+ min) | 20 | $1,289 | $64 |
2022: 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 154 | $30,219 | $194 |
| New patient visit (15+ min) | 296 | $13,049 | $44 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 64 | $11,903 | $186 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 156 | $11,339 | $72 |
| Diagnostic exam of large bowel using a flexible endoscope | 59 | $8,407 | $142 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 44 | $8,204 | $186 |
| Short return visit | 177 | $7,697 | $35 |
| Short return visit (20+ min) | 111 | $6,949 | $60 |
| New patient visit (30+ min) | 43 | $3,808 | $89 |
2021: 8 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 92 | $18,436 | $200 |
| New patient visit (15+ min) | 281 | $12,436 | $44 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 158 | $12,136 | $76 |
| Diagnostic exam of large bowel using a flexible endoscope | 66 | $9,458 | $141 |
| Short return visit | 186 | $8,761 | $36 |
| Short return visit (20+ min) | 85 | $4,964 | $58 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 26 | $4,931 | $190 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 24 | $4,557 | $190 |
2020: 8 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 97 | $18,111 | $183 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 152 | $11,332 | $75 |
| Diagnostic exam of large bowel using a flexible endoscope | 82 | $10,463 | $126 |
| New patient visit (15+ min) | 281 | $10,269 | $37 |
| Short return visit (20+ min) | 146 | $6,207 | $41 |
| Short return visit | 158 | $4,513 | $22 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 22 | $4,032 | $183 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $2,551 | $182 |
2019: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 165 | $30,295 | $184 |
| New patient visit (15+ min) | 414 | $18,782 | $45 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 234 | $16,957 | $72 |
| Diagnostic exam of large bowel using a flexible endoscope | 120 | $16,415 | $137 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 69 | $12,539 | $182 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 54 | $9,783 | $181 |
| Short return visit (20+ min) | 123 | $6,413 | $52 |
| Short return visit | 172 | $6,308 | $32 |
| Biopsy of large bowel using a flexible endoscope | 16 | $2,283 | $143 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 12 | $1,480 | $123 |
2018: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 140 | $25,511 | $178 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 121 | $21,544 | $178 |
| New patient visit (15+ min) | 459 | $20,082 | $44 |
| Diagnostic exam of large bowel using a flexible endoscope | 92 | $12,269 | $133 |
| Biopsy of large bowel using a flexible endoscope | 78 | $10,898 | $140 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 58 | $10,438 | $180 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 146 | $9,090 | $62 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 90 | $6,187 | $68 |
| Short return visit (20+ min) | 123 | $5,884 | $48 |
| Short return visit | 139 | $5,290 | $31 |
2017: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 142 | $24,410 | $172 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 101 | $18,101 | $179 |
| New patient visit (15+ min) | 306 | $13,774 | $45 |
| Biopsy of large bowel using a flexible endoscope | 93 | $13,456 | $145 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 59 | $10,550 | $179 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 103 | $8,047 | $77 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 115 | $7,079 | $62 |
| Diagnostic exam of large bowel using a flexible endoscope | 44 | $6,220 | $138 |
| Short return visit | 166 | $5,951 | $30 |
| Short return visit (20+ min) | 67 | $3,219 | $47 |
2016: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 145 | $28,426 | $195 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 130 | $24,612 | $189 |
| New patient visit (15+ min) | 313 | $15,252 | $49 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 66 | $12,554 | $190 |
| Biopsy of large bowel using a flexible endoscope | 68 | $9,893 | $145 |
| Diagnostic exam of large bowel using a flexible endoscope | 69 | $9,874 | $143 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 141 | $9,355 | $66 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 98 | $7,904 | $80 |
| Short return visit | 183 | $6,955 | $31 |
| Short return visit (20+ min) | 96 | $4,942 | $51 |
2015: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 115 | $26,978 | $229 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 98 | $20,237 | $207 |
| Biopsy of large bowel using a flexible endoscope | 94 | $18,527 | $197 |
| Diagnostic exam of large bowel using a flexible endoscope | 112 | $17,302 | $153 |
| New patient visit (15+ min) | 258 | $13,568 | $53 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 151 | $10,660 | $70 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 51 | $10,532 | $207 |
| Short return visit (20+ min) | 93 | $4,851 | $52 |
| Short return visit | 134 | $4,801 | $32 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 64 | $4,639 | $71 |
| New patient visit (30+ min) | 90 | $4,163 | $46 |
2014: 10 services
| New patient visit (30+ min) | 323 | $24,867 | $77 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 78 | $19,019 | $241 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 87 | $18,896 | $215 |
| Diagnostic exam of large bowel using a flexible endoscope | 101 | $17,662 | $173 |
| Biopsy of large bowel using a flexible endoscope | 69 | $13,972 | $202 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 108 | $8,670 | $79 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 33 | $7,213 | $219 |
| Short return visit (20+ min) | 126 | $7,009 | $55 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 60 | $5,468 | $91 |
| Short return visit | 129 | $5,162 | $33 |
2013: 10 services
| New patient visit (30+ min) | 328 | $25,497 | $78 |
| Diagnostic exam of large bowel using a flexible endoscope | 133 | $22,544 | $170 |
| Biopsy of large bowel using a flexible endoscope | 86 | $17,674 | $206 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 61 | $14,923 | $241 |
| Short return visit (20+ min) | 190 | $10,412 | $53 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 45 | $9,792 | $218 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 109 | $9,427 | $86 |
| Short return visit | 196 | $8,317 | $34 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 38 | $8,221 | $216 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 64 | $6,403 | $100 |
Medicaid work
$920,033 in 2024
Medicaid paid $920,033 for 5,666 billed services this clinician did in 2024, up to 159 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| DIAGNOSTIC COLONOSCOPY | 1,116 | $382,372 |
| Upper gastrointestinal endoscopy with biopsy | 1,152 | $247,300 |
| COLONOSCOPY W/LESION REMOVAL | 360 | $122,352 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 1,152 | $55,981 |
| Service | 257 | $40,299 |
| New patient visit (30+ min) | 370 | $28,632 |
| Short return visit | 722 | $24,677 |
| Short return visit (20+ min) | 273 | $14,135 |
| Service | 105 | $3,343 |
| Ringers lactate infusion, up to 1000 cc | 64 | $625 |
| Injection, propofol, 10 mg | 68 | $223 |
| Injection, diphenhydramine hcl, up to 50 mg | 13 | $76 |
| 2024 | 5,666 | 13 | 159 | $920,033 |
| 2023 | 7,213 | 10 | 211 | $1,055,123 |
| 2022 | 6,764 | 9 | 202 | $950,731 |
| 2021 | 5,780 | 10 | 191 | $813,915 |
| 2020 | 4,737 | 10 | 152 | $641,937 |
| 2019 | 6,840 | 11 | 215 | $1,145,758 |
| 2018 | 7,261 | 11 | 237 | $1,146,487 |
See the largest Medicaid services in earlier years
2023
| DIAGNOSTIC COLONOSCOPY | 1,284 | $419,542 |
| Upper gastrointestinal endoscopy with biopsy | 1,238 | $252,624 |
| COLONOSCOPY W/LESION REMOVAL | 452 | $156,766 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 1,714 | $80,298 |
| Service | 301 | $53,558 |
| Short return visit | 1,189 | $35,166 |
| New patient visit (30+ min) | 410 | $33,751 |
| Short return visit (20+ min) | 312 | $13,837 |
| Service | 299 | $9,581 |
| Service | 14 | $0 |
2022
| DIAGNOSTIC COLONOSCOPY | 1,028 | $295,231 |
| Upper gastrointestinal endoscopy with biopsy | 1,300 | $275,647 |
| COLONOSCOPY W/LESION REMOVAL | 484 | $159,525 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 1,619 | $76,768 |
| Service | 307 | $62,551 |
| Short return visit | 984 | $28,749 |
| New patient visit (30+ min) | 352 | $26,025 |
| Short return visit (20+ min) | 356 | $14,786 |
| Service | 334 | $11,449 |
2021
| Upper gastrointestinal endoscopy with biopsy | 1,267 | $344,498 |
| DIAGNOSTIC COLONOSCOPY | 690 | $208,644 |
| COLONOSCOPY W/LESION REMOVAL | 325 | $124,256 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 1,593 | $79,117 |
| Short return visit | 1,006 | $31,153 |
| Short return visit (20+ min) | 287 | $12,348 |
| Service | 28 | $8,186 |
| Service | 308 | $5,713 |
| Service | 169 | $0 |
| Service | 107 | $0 |
2020
| Upper gastrointestinal endoscopy with biopsy | 1,026 | $229,514 |
| DIAGNOSTIC COLONOSCOPY | 621 | $181,099 |
| COLONOSCOPY W/LESION REMOVAL | 290 | $94,375 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 1,396 | $73,093 |
| Short return visit | 783 | $22,102 |
| Service | 75 | $21,926 |
| Short return visit (20+ min) | 336 | $14,029 |
| Service | 174 | $5,801 |
| Service | 18 | $0 |
| Service | 18 | $0 |
2019
| DIAGNOSTIC COLONOSCOPY | 1,220 | $361,511 |
| Upper gastrointestinal endoscopy with biopsy | 1,513 | $338,070 |
| COLONOSCOPY W/LESION REMOVAL | 695 | $246,493 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 1,830 | $96,466 |
| Service | 231 | $60,424 |
| Short return visit | 629 | $18,594 |
| Short return visit (20+ min) | 290 | $13,213 |
| Service | 318 | $10,890 |
| Infusion, normal saline solution , 1000 cc | 14 | $98 |
| Service | 74 | $0 |
| Service | 26 | $0 |
2018
| DIAGNOSTIC COLONOSCOPY | 1,437 | $425,516 |
| Diagnostic upper gastrointestinal endoscopy | 951 | $178,227 |
| COLONOSCOPY W/LESION REMOVAL | 447 | $154,740 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 2,305 | $130,899 |
| COLONOSCOPY AND BIOPSY | 306 | $79,005 |
| Service | 221 | $63,988 |
| Upper gastrointestinal endoscopy with biopsy | 372 | $60,534 |
| Short return visit (20+ min) | 373 | $23,936 |
| Short return visit | 534 | $17,535 |
| Service | 289 | $12,107 |
| Service | 26 | $0 |
Drugs they prescribed that Part D paid
$73,016
Pharmacies billed $73,016 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 767) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
673 generic and 94 brand-name prescriptions · $73,016 in drug cost · 91 antibiotic prescriptions to 43 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 44 | $31,054 | $706 |
| Nexium | 12 | $4,329 | $361 |
| Pyridostigmine | 21 | $1,569 | $75 |
| Dicyclomine | 52 | $1,502 | $29 |
| Famotidine | 89 | $1,445 | $16 |
See all 17 drugs
| Linzess | 44 | $31,054 | $706 |
| Nexium | 12 | $4,329 | $361 |
| Pyridostigmine | 21 | $1,569 | $75 |
| Dicyclomine | 52 | $1,502 | $29 |
| Famotidine | 89 | $1,445 | $16 |
| Pantoprazole | 127 | $1,423 | $11 |
| Sucralfate | 43 | $1,181 | $27 |
| Omeprazole | 85 | $900 | $11 |
| Diphenoxylate-Atropine | 14 | $821 | $59 |
| Cholestyramine | 15 | $766 | $51 |
| Clarithromycin | 32 | $728 | $23 |
| Esomeprazole Magnesium | 18 | $617 | $34 |
| Lansoprazole | 13 | $481 | $37 |
| Lactulose | 22 | $366 | $17 |
| Promethazine | 15 | $226 | $15 |
| Amoxicillin | 32 | $209 | $7 |
| Constulose | 11 | $205 | $19 |
Year by year
| 2024 | 767 | 249 | 0% (0) | 12% | $73,016 |
| 2023 | 839 | 219 | 0% (0) | 8% | $66,828 |
| 2022 | 710 | 189 | 0% (0) | None | $50,752 |
| 2021 | 627 | 150 | None | 10% | $43,128 |
| 2020 | 519 | 145 | 0% (0) | 11% | $29,510 |
| 2019 | 493 | 165 | 0% (0) | 17% | $32,132 |
| 2018 | 920 | 454 | 0% (0) | 8% | $40,973 |
| 2017 | 828 | 433 | 0% (0) | 10% | $39,919 |
| 2016 | 845 | 528 | None | None | $40,924 |
| 2015 | 820 | 460 | None | 15% | $39,989 |
| 2014 | 604 | 298 | None | 28% | $38,572 |
| 2013 | 920 | 472 | 0% (0) | 37% | $51,492 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Linzess | 31 | $27,128 | $875 |
| Nexium | 19 | $8,147 | $429 |
| Dexlansoprazole Dr | 26 | $7,747 | $298 |
| Pantoprazole | 159 | $3,177 | $20 |
| Esomeprazole Magnesium | 16 | $2,748 | $172 |
| Dicyclomine | 52 | $2,598 | $50 |
| Omeprazole | 170 | $2,409 | $14 |
| Clarithromycin | 37 | $1,275 | $34 |
| Pyridostigmine | 20 | $1,086 | $54 |
| Famotidine | 66 | $1,050 | $16 |
| Sucralfate | 26 | $998 | $38 |
| Lactulose | 32 | $718 | $22 |
| Diphenoxylate-Atropine | 16 | $636 | $40 |
| Amoxicillin | 44 | $517 | $12 |
| Ondansetron Odt | 11 | $324 | $29 |
2022: 13 drugs
| Dexilant | 26 | $13,722 | $528 |
| Dexlansoprazole Dr | 13 | $5,019 | $386 |
| Esomeprazole Magnesium | 15 | $3,048 | $203 |
| Pyridostigmine | 38 | $2,729 | $72 |
| Omeprazole | 168 | $1,771 | $11 |
| Pantoprazole | 101 | $1,613 | $16 |
| Hydrocortisone | 25 | $1,301 | $52 |
| Dicyclomine | 32 | $1,162 | $36 |
| Clarithromycin | 23 | $1,017 | $44 |
| Diphenoxylate-Atropine | 22 | $800 | $36 |
| Famotidine | 79 | $798 | $10 |
| Lactulose | 20 | $580 | $29 |
| Amoxicillin | 22 | $224 | $10 |
2021: 15 drugs
| Dexilant | 27 | $10,479 | $388 |
| Linzess | 14 | $8,301 | $593 |
| Diphenoxylate-Atropine | 27 | $1,957 | $72 |
| Cholestyramine | 13 | $1,573 | $121 |
| Omeprazole | 156 | $1,506 | $10 |
| Pyridostigmine | 24 | $1,403 | $58 |
| Famotidine | 78 | $962 | $12 |
| Clarithromycin | 17 | $679 | $40 |
| Dicyclomine | 18 | $585 | $32 |
| Esomeprazole Magnesium | 14 | $580 | $41 |
| Pantoprazole | 45 | $415 | $9 |
| Nystatin | 12 | $343 | $29 |
| Amoxicillin | 23 | $266 | $12 |
| Amitriptyline | 14 | $187 | $13 |
| Hydrocortisone | 13 | $172 | $13 |
2020: 14 drugs
| Dexilant | 37 | $13,327 | $360 |
| Diphenoxylate-Atropine | 24 | $2,024 | $84 |
| Omeprazole | 158 | $1,240 | $8 |
| Ondansetron Odt | 16 | $925 | $58 |
| Clarithromycin | 17 | $770 | $45 |
| Pyridostigmine | 15 | $761 | $51 |
| Famotidine | 31 | $455 | $15 |
| Sulfasalazine | 13 | $419 | $32 |
| Dicyclomine | 17 | $412 | $24 |
| Nystatin | 11 | $277 | $25 |
| Pantoprazole | 38 | $248 | $7 |
| Buspirone | 14 | $178 | $13 |
| Lidocaine Hcl Viscous | 14 | $140 | $10 |
| Amoxicillin | 19 | $137 | $7 |
2019: 13 drugs
| Dexilant | 48 | $14,054 | $293 |
| Esomeprazole Magnesium | 35 | $2,291 | $65 |
| Diphenoxylate-Atropine | 19 | $2,051 | $108 |
| Hydrocortisone | 20 | $1,572 | $79 |
| Omeprazole | 147 | $1,454 | $10 |
| Clarithromycin | 14 | $697 | $50 |
| Pantoprazole | 30 | $380 | $13 |
| Sulfasalazine | 11 | $372 | $34 |
| Polyethylene Glycol 3350 | 14 | $318 | $23 |
| Ranitidine | 24 | $238 | $10 |
| Famotidine | 16 | $219 | $14 |
| Gavilyte-G | 15 | $213 | $14 |
| Amoxicillin | 16 | $195 | $12 |
2018: 13 drugs
| Dexilant | 41 | $11,677 | $285 |
| Esomeprazole Magnesium | 56 | $7,921 | $141 |
| Linzess | 12 | $5,498 | $458 |
| Polyethylene Glycol 3350 | 337 | $5,215 | $15 |
| Nexium | 11 | $3,688 | $335 |
| Omeprazole | 177 | $1,487 | $8 |
| Pantoprazole | 60 | $585 | $10 |
| Ranitidine | 47 | $417 | $9 |
| Ondansetron | 21 | $408 | $19 |
| Gavilyte-G | 16 | $228 | $14 |
| Famotidine | 22 | $139 | $6 |
| Hydrocortisone | 14 | $124 | $9 |
| Dicyclomine | 13 | $79 | $6 |
2017: 13 drugs
| Nexium | 31 | $9,409 | $304 |
| Dexilant | 25 | $6,801 | $272 |
| Linzess | 12 | $6,264 | $522 |
| Esomeprazole Magnesium | 40 | $4,939 | $123 |
| Polyethylene Glycol 3350 | 344 | $4,780 | $14 |
| Omeprazole | 100 | $637 | $6 |
| Pantoprazole | 46 | $448 | $10 |
| Lactulose | 16 | $443 | $28 |
| Hydrocortisone | 17 | $355 | $21 |
| Ranitidine | 49 | $349 | $7 |
| Ondansetron | 14 | $195 | $14 |
| Gavilyte-G | 11 | $147 | $13 |
| Dicyclomine | 19 | $106 | $6 |
2016: 14 drugs
| Dexilant | 37 | $10,836 | $293 |
| Nexium | 40 | $10,227 | $256 |
| Delzicol | 12 | $6,538 | $545 |
| Polyethylene Glycol 3350 | 434 | $4,151 | $10 |
| Esomeprazole Magnesium | 17 | $1,826 | $107 |
| Diphenoxylate-Atropine | 20 | $1,061 | $53 |
| Omeprazole | 90 | $624 | $7 |
| Lactulose | 21 | $351 | $17 |
| Ondansetron | 20 | $288 | $14 |
| Ranitidine | 23 | $206 | $9 |
| Hydrocortisone | 20 | $191 | $10 |
| Lansoprazole | 11 | $115 | $10 |
| Dicyclomine | 12 | $104 | $9 |
| Pantoprazole | 14 | $94 | $7 |
2015: 12 drugs
| Nexium | 58 | $14,977 | $258 |
| Dexilant | 30 | $7,663 | $255 |
| Polyethylene Glycol 3350 | 372 | $3,753 | $10 |
| Esomeprazole Magnesium | 12 | $2,241 | $187 |
| Ondansetron | 13 | $1,097 | $84 |
| Diphenoxylate-Atropine | 20 | $995 | $50 |
| Omeprazole | 113 | $928 | $8 |
| Lactulose | 50 | $793 | $16 |
| Hydrocortisone | 27 | $299 | $11 |
| Lansoprazole | 12 | $222 | $18 |
| Dicyclomine | 11 | $155 | $14 |
| Pantoprazole | 15 | $112 | $7 |
2014: 11 drugs
| Nexium | 52 | $15,308 | $294 |
| Dexilant | 30 | $7,269 | $242 |
| Polyethylene Glycol 3350 | 87 | $1,479 | $17 |
| Moviprep | 17 | $1,295 | $76 |
| Omeprazole | 127 | $1,105 | $9 |
| Peg-3350 and Electrolytes | 71 | $1,070 | $15 |
| Lactulose | 40 | $545 | $14 |
| Gavilyte-G | 28 | $389 | $14 |
| Diphenoxylate-Atropine | 12 | $323 | $27 |
| Hydrocortisone | 27 | $222 | $8 |
| Pantoprazole | 14 | $207 | $15 |
2013: 15 drugs
| Nexium | 90 | $25,340 | $282 |
| Dexilant | 31 | $5,648 | $182 |
| Peg-3350 and Electrolytes | 225 | $3,549 | $16 |
| Omeprazole | 179 | $2,310 | $13 |
| Gavilyte-G | 97 | $1,511 | $16 |
| Lansoprazole | 12 | $764 | $64 |
| Sucralfate | 14 | $489 | $35 |
| Peg 3350-Electrolyte | 41 | $468 | $11 |
| Diphenoxylate-Atropine | 20 | $390 | $19 |
| Hydrocortisone | 38 | $385 | $10 |
| Lactulose | 29 | $375 | $13 |
| Pantoprazole | 19 | $275 | $14 |
| Golytely | 13 | $243 | $19 |
| Gavilyte-C | 13 | $204 | $16 |
| Propranolol | 15 | $142 | $9 |
Money from drug and device companies
$20 in 2025
| 2025 | 1 | 1 | None | $20 |
| 2023 | 3 | 5 | None | $100 |
| 2022 | 3 | 7 | None | $127 |
| 2021 | 3 | 5 | None | $107 |
| 2020 | 3 | 7 | None | $139 |
| 2019 | 1 | 1 | None | $15 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Orcapod | $20 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2025-05-08 | Orcapod | $20 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $100
| Ironwood Pharmaceuticals | Linzess | $52 | 3 payments
|
| Genzyme | Dupixent | $26 | 1 payment
|
| Janssen Biotech | Stelara | $22 | 1 payment
|
2022: $127
| Janssen Biotech | Stelara | $99 | 5 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $14 | 1 payment
|
| RedHill Biopharma | Talicia | $14 | 1 payment
|
2021: $107
| Janssen Biotech | Stelara | $68 | 3 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $20 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $19 | 1 payment
|
2020: $139
| Janssen Biotech | Stelara | $106 | 5 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $17 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $16 | 1 payment
|
2019: $15
| Ferring Pharmaceuticals | Clenpiq | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 25.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1386679611
- Licence
- CA A035467
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A354671
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 1069 E Hawkeye Ave Ste A, Turlock, CA, 95380
- NPI first listed
- 2006-07-12
- NPI last updated
- 2014-07-18
This is when the NPI record was last certified, not a medical board exam.